180 related articles for article (PubMed ID: 19843689)
21. Clinical significance of intensive endoscopic screening for synchronous esophageal neoplasm in patients with head and neck squamous cell carcinoma.
Kim DH; Gong EJ; Jung HY; Lim H; Ahn JY; Choi KS; Lee JH; Choi KD; Song HJ; Lee GH; Kim JH; Roh JL; Choi SH; Nam SY; Kim SY; Baek S
Scand J Gastroenterol; 2014 Dec; 49(12):1486-92. PubMed ID: 25372595
[TBL] [Abstract][Full Text] [Related]
22. Quantification of the major urinary metabolite of PGE2 by a liquid chromatographic/mass spectrometric assay: determination of cyclooxygenase-specific PGE2 synthesis in healthy humans and those with lung cancer.
Murphey LJ; Williams MK; Sanchez SC; Byrne LM; Csiki I; Oates JA; Johnson DH; Morrow JD
Anal Biochem; 2004 Nov; 334(2):266-75. PubMed ID: 15494133
[TBL] [Abstract][Full Text] [Related]
23. Correlation of cyclooxygenase-2 pathway and VEGF expression in head and neck squamous cell carcinoma.
Lim SC; Park SY; Do NY
Oncol Rep; 2003; 10(5):1073-9. PubMed ID: 12883661
[TBL] [Abstract][Full Text] [Related]
24. [Neutrophil to lymphocyte ratio in peripheral blood: a novel independent prognostic factor in patients with head and neck squamous cell carcinoma].
Wu F; Wu LL; Zhu LX
Zhonghua Zhong Liu Za Zhi; 2017 Jan; 39(1):29-32. PubMed ID: 28104030
[No Abstract] [Full Text] [Related]
25. Role of cyclooxygenase-2 in tumor progression and survival of head and neck squamous cell carcinoma.
Saba NF; Choi M; Muller S; Shin HJ; Tighiouart M; Papadimitrakopoulou VA; El-Naggar AK; Khuri FR; Chen ZG; Shin DM
Cancer Prev Res (Phila); 2009 Sep; 2(9):823-9. PubMed ID: 19737986
[TBL] [Abstract][Full Text] [Related]
26. Inflammatory mediators drive metastasis and drug resistance in head and neck squamous cell carcinoma.
St John MA
Laryngoscope; 2015 Mar; 125 Suppl 3():S1-11. PubMed ID: 25646683
[TBL] [Abstract][Full Text] [Related]
27. Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients.
Khuri FR; Lee JJ; Lippman SM; Kim ES; Cooper JS; Benner SE; Winn R; Pajak TF; Williams B; Shenouda G; Hodson I; Fu K; Shin DM; Vokes EE; Feng L; Goepfert H; Hong WK
J Natl Cancer Inst; 2006 Apr; 98(7):441-50. PubMed ID: 16595780
[TBL] [Abstract][Full Text] [Related]
28. Classical risk factors, but not HPV status, predict survival after chemoradiotherapy in advanced head and neck cancer patients.
Descamps G; Karaca Y; Lechien JR; Kindt N; Decaestecker C; Remmelink M; Larsimont D; Andry G; Hassid S; Rodriguez A; Khalife M; Journe F; Saussez S
J Cancer Res Clin Oncol; 2016 Oct; 142(10):2185-96. PubMed ID: 27370781
[TBL] [Abstract][Full Text] [Related]
29. Prospective study of urinary prostaglandin E2 metabolite and pancreatic cancer risk.
Cui Y; Shu XO; Li HL; Yang G; Wen W; Gao YT; Cai Q; Rothman N; Yin HY; Lan Q; Xiang YB; Zheng W
Int J Cancer; 2017 Dec; 141(12):2423-2429. PubMed ID: 28815606
[TBL] [Abstract][Full Text] [Related]
30. The influence of cyclooxygenase-1 expression on the efficacy of cyclooxygenase-2 inhibition in head and neck squamous cell carcinoma cell lines.
Park SW; Kim HS; Choi MS; Kim JE; Jeong WJ; Heo DS; Sung MW
Anticancer Drugs; 2011 Jun; 22(5):416-23. PubMed ID: 21301321
[TBL] [Abstract][Full Text] [Related]
31. Epidermal growth factor-induced cyclooxygenase-2 enhances head and neck squamous cell carcinoma metastasis through fibronectin up-regulation.
Hsu JY; Chang KY; Chen SH; Lee CT; Chang ST; Cheng HC; Chang WC; Chen BK
Oncotarget; 2015 Jan; 6(3):1723-39. PubMed ID: 25595899
[TBL] [Abstract][Full Text] [Related]
32. High Level of Tobacco Carcinogen-Derived DNA Damage in Oral Cells Is an Independent Predictor of Oral/Head and Neck Cancer Risk in Smokers.
Khariwala SS; Ma B; Ruszczak C; Carmella SG; Lindgren B; Hatsukami DK; Hecht SS; Stepanov I
Cancer Prev Res (Phila); 2017 Sep; 10(9):507-513. PubMed ID: 28679497
[TBL] [Abstract][Full Text] [Related]
33. A matched control study of treatment outcome in young patients with squamous cell carcinoma of the head and neck.
Verschuur HP; Irish JC; O'Sullivan B; Goh C; Gullane PJ; Pintilie M
Laryngoscope; 1999 Feb; 109(2 Pt 1):249-58. PubMed ID: 10890775
[TBL] [Abstract][Full Text] [Related]
34. Survival analysis of head and neck squamous cell carcinoma: influence of smoking and drinking.
Farshadpour F; Kranenborg H; Calkoen EV; Hordijk GJ; Koole R; Slootweg PJ; Terhaard CH
Head Neck; 2011 Jun; 33(6):817-23. PubMed ID: 20737489
[TBL] [Abstract][Full Text] [Related]
35. Proton pump inhibitors and histamine 2 blockers are associated with improved overall survival in patients with head and neck squamous carcinoma.
Papagerakis S; Bellile E; Peterson LA; Pliakas M; Balaskas K; Selman S; Hanauer D; Taylor JM; Duffy S; Wolf G
Cancer Prev Res (Phila); 2014 Dec; 7(12):1258-69. PubMed ID: 25468899
[TBL] [Abstract][Full Text] [Related]
36. Increased expression of miR-93 is associated with poor prognosis in head and neck squamous cell carcinoma.
Li G; Ren S; Su Z; Liu C; Deng T; Huang D; Tian Y; Qiu Y; Liu Y
Tumour Biol; 2015 May; 36(5):3949-56. PubMed ID: 25578493
[TBL] [Abstract][Full Text] [Related]
37. The prognostic value of Tiam1 protein expression in head and neck squamous cell carcinoma: a retrospective study.
Yang H; Cai YC; Cao Y; Song M; An X; Xia Y; Wei J; Jiang WQ; Shi YX
Chin J Cancer; 2015 Sep; 34(12):614-21. PubMed ID: 26369827
[TBL] [Abstract][Full Text] [Related]
38. Durvalumab for recurrent or metastatic head and neck squamous cell carcinoma: Results from a single-arm, phase II study in patients with ≥25% tumour cell PD-L1 expression who have progressed on platinum-based chemotherapy.
Zandberg DP; Algazi AP; Jimeno A; Good JS; Fayette J; Bouganim N; Ready NE; Clement PM; Even C; Jang RW; Wong S; Keilholz U; Gilbert J; Fenton M; Braña I; Henry S; Remenar E; Papai Z; Siu LL; Jarkowski A; Armstrong JM; Asubonteng K; Fan J; Melillo G; Mesía R
Eur J Cancer; 2019 Jan; 107():142-152. PubMed ID: 30576970
[TBL] [Abstract][Full Text] [Related]
39. Smoking and drinking can induce p15 methylation in the upper aerodigestive tract of healthy individuals and patients with head and neck squamous cell carcinoma.
Chang HW; Ling GS; Wei WI; Yuen AP
Cancer; 2004 Jul; 101(1):125-32. PubMed ID: 15221997
[TBL] [Abstract][Full Text] [Related]
40. Lymph node ratio as a prognostic factor for survival in patients with head and neck squamous cell carcinoma.
Sano D; Yabuki K; Takahashi H; Arai Y; Chiba Y; Tanabe T; Nishimura G; Oridate N
Auris Nasus Larynx; 2018 Aug; 45(4):846-853. PubMed ID: 29203318
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
